| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | -29.8% |
| Cost of Revenue | $1.9M | +600.7% |
| R&D Expense | $314.2M | +110.3% |
| SG&A Expense | $175.1M | +1.1% |
| Operating Income | -$500.0M | -56.5% |
| Interest Expense | $12.1M | — |
| Pre-tax Income | -$499.6M | -41.6% |
| Income Tax | $598K | +657.0% |
| Net Income | -$500.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $302.3M | -42.4% |
| Short-term Investments | $606.7M | +664.0% |
| Inventory | $24.0M | -19.0% |
| Current Assets | $1.00B | +47.6% |
| Total Assets | $1.14B | +6.7% |
| Current Liabilities | $184.1M | +39.9% |
| Total Liabilities | $659.7M | +277.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$380.2M | -64.8% |
| Capital Expenditures | $16.5M | +255.7% |
| Investing Cash Flow | -$286.2M | +26.2% |
| Financing Cash Flow | $459.0M | -6.2% |
| Free Cash Flow | -$396.7M | -68.5% |
| -41.7% |
| EPS (Basic) | -$1.89 | -32.2% |
| EPS (Diluted) | -$1.89 | -32.2% |
| Stockholders' Equity |
| $480.2M |
| -46.3% |